Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Ahzantive™ (aflibercept-mrbb) – New biosimilar approval

July 1, 2024 - Formycon announced the FDA approval of Ahzantive (aflibercept-mrbb), biosimilar to Regeneron’s Eylea (aflibercept).

Download PDF

Rx navigation